In cancer, HER3 can stimulate the oncogenic activity of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) and the resistance to HER-targeted cancer therapies3,4. The gene discussed is ERBB3; the disease is cancer.